Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study
2007

Antiphospholipid Antibodies in Multiple Sclerosis

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): Bidot Carlos J, Horstman Lawrence L, Jy Wenche, Jimenez Joaquin J, Bidot Carlos Jr, Ahn Yeon S, Alexander J Steven, Gonzalez-Toledo Eduardo, Kelley Roger E, Minagar Alireza

Primary Institution: University of Miami Dept. of Medicine, Miller School Of Medicine

Hypothesis

Is there a relationship between antiphospholipid antibodies and clinical features in multiple sclerosis patients?

Conclusion

Increased antiphospholipid antibodies are associated with exacerbations of multiple sclerosis.

Supporting Evidence

  • 80% of MS subjects in exacerbation had elevated IgM antibodies.
  • Less than half of MS patients in remission had elevated IgM antibodies.
  • None of the MS patients had elevated IgG against any of the target antigens.

Takeaway

This study found that people with multiple sclerosis have more antibodies when their symptoms get worse, but we don't know why yet.

Methodology

The study involved 24 subjects with relapsing-remitting MS who underwent MRI and blood tests for antiphospholipid antibodies.

Limitations

The study is preliminary and involves a small sample size.

Participant Demographics

20 females and 4 males with a mean duration of neurological symptoms prior to diagnosis of 5.3 months.

Statistical Information

P-Value

p = 0.0002

Statistical Significance

p < 0.01

Digital Object Identifier (DOI)

10.1186/1471-2377-7-36

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication